(Investigator site)

Calgary, Alberta T2N 2T9

0 studies enrolling now · 2 studies all time

What they study most

Clostridioides Difficile Infection, Clostridium Difficile Infection

Studies at this site

• ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection — Completed
• ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection — Completed